Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095

被引：0
|
作者：
Ali Afshar-Oromieh
Uwe Haberkorn
Christian Zechmann
Thomas Armor
Walter Mier
Fabian Spohn
Nils Debus
Tim Holland-Letz
John Babich
Clemens Kratochwil
机构：
[1] Heidelberg University Hospital,Department of Nuclear Medicine
[2] German Cancer Research Center,Clinical Cooperation Unit Nuclear Medicine
[3] Progenics Pharmaceuticals,Department of Biostatistics
[4] Inc.,Division of Radiopharmaceutical Sciences, Department of Radiology
[5] German Cancer Research Center,Citigroup Biomedical Imaging Center
[6] Weill Cornell Medicine,Meyer Cancer Center
[7] Weill Cornell Medicine,undefined
[8] Weill Cornell Medicine,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Prostate cancer; PSMA; Prostate-specific membrane antigen; Endoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：950 / 959
页数：9
相关论文
共 50 条
  • [1] Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
    Afshar-Oromieh, Ali
    Haberkorn, Uwe
    Zechmann, Christian
    Armor, Thomas
    Mier, Walter
    Spohn, Fabian
    Debus, Nils
    Holland-Letz, Tim
    Babich, John
    Kratochwil, Clemens
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 950 - 959
  • [2] Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
    Christian M. Zechmann
    Ali Afshar-Oromieh
    Tom Armor
    James B. Stubbs
    Walter Mier
    Boris Hadaschik
    John Joyal
    Klaus Kopka
    Jürgen Debus
    John W. Babich
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1280 - 1292
  • [3] Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
    Zechmann, Christian M.
    Afshar-Oromieh, Ali
    Armor, Tom
    Stubbs, James B.
    Mier, Walter
    Hadaschik, Boris
    Joyal, John
    Kopka, Klaus
    Debus, Juergen
    Babich, John W.
    Haberkorn, Uwe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1280 - 1292
  • [4] A phase 2, single-arm trial evaluating 131I-PSMA-1095 targeted radioligand therapy for metastatic castration-resistant prostate cancer
    Liu, Richard F.
    Ferrario, Cristiano
    Fallah, Parvaneh
    Rose, April A. N.
    Labidi, Soumaya
    Mamo, Aline
    Probst, Stephan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (08) : 683 - 689
  • [5] Targeting metastatic prostate cancer [PCa] in patients with 123I-MIP1072 & 123I-MIP1095
    Barrett, John
    LaFrance, Norman
    Coleman, R. Edward
    Goldsmith, Stanley
    Stubbs, James
    Petry, Neil
    Vallabhajosula, Shankar
    Maresca, Kevin
    Femia, Frank
    Babich, John
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [6] Preliminary evaluation of prostate-targeted radiotherapy using 131I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs
    Tesson, Mathias
    Rae, Colin
    Nixon, Colin
    Babich, John W.
    Mairs, Robert J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (07) : 912 - 921
  • [7] PSMA Radioligand Therapy in Prostate Cancer
    Almeida, Ludmila Santiago
    Etchebehere, Elba Cristina Sa de Camargo
    Megias, Irene Garcia
    Teran, Adriana K. Calapaqui
    Hadaschik, Boris
    Colletti, Patrick M.
    Herrmann, Ken
    Giammarile, Francesco
    Bolton, Roberto C. Delgado
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 45 - 55
  • [8] Radioligand Therapy of metastatic Prostate Cancer with Lu-PSMA-617
    Manych, Matthias
    AKTUELLE UROLOGIE, 2017, 48 (05)
  • [9] Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
    Derks, Yvonne H. W.
    Schilham, Melline G. M.
    Rijpkema, Mark
    Smeets, Esther M. M.
    Amatdjais-Groenen, Helene I. V.
    Kip, Annemarie
    van Lith, Sanne A. M.
    van de Kamp, Jill
    Sedelaar, J. P. Michiel
    Somford, Diederik M.
    Simons, Michiel
    Laverman, Peter
    Gotthardt, Martin
    Lowik, Dennis W. P. M.
    Heskamp, Sandra
    Lutje, Susanne
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) : 2872 - 2884
  • [10] Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
    Yvonne H. W. Derks
    Melline G. M. Schilham
    Mark Rijpkema
    Esther M. M. Smeets
    Helene I. V. Amatdjais-Groenen
    Annemarie Kip
    Sanne A. M. van Lith
    Jill van de Kamp
    J. P. Michiel Sedelaar
    Diederik M. Somford
    Michiel Simons
    Peter Laverman
    Martin Gotthardt
    Dennis W. P. M. Löwik
    Sandra Heskamp
    Susanne Lütje
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2872 - 2884
12345